Ci Dendreon Corporation
Dendreon Pharmaceuticals LLC is a biotechnology company. Its lead product, Provenge, is an immunotherapy for prostate cancer. It consists of a mixture of the patient's own blood cells that have been incubated with the Dendreon PAP-GM-CSF fusion protein. Phase III clinical trial results demonstrating a survival benefit for prostate cancer patients receiving the drug were presented at the AUA meeting on April 28, 2009. After going through the approval process, Provenge was given full approval by the FDA on April 29, 2010. Dendreon's stock value fell 66% on August 4, 2011, after abandoning its forecast for its debut drug Provenge.
Source: Wikipedia
Kër bu magCorporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Sos nañu ko2013
NekkinDox
Brevet134 brevet
HUMORAL IMMUNE RESPONSE AGAINST TUMOR ANTIGENS AFTER TREATMENT WITH A CANCER ANTIGEN SPECIFIC ACTIVE IMMUNOTHERAPY AND ITS ASSOCIATION WITH…CA2923433C · 2020
Humoral immune response against tumor antigens after treatment with a cancer antigen specific active immunotherapy and its association with…US10261091B2 · 2019
Duggal ngir gis 134 patant yépp
Seet portfolio patant yépp, ak nimero publikaasiyon yi, bés yi ak njaboot yi.
Dugg Sos ab kont ak sa imeelAmul fay
Bu nga wéyee, nangu nga Déggoo jëfandikukat bi, Politig sutura bi ak Politig cookies yi yu Heelky.
Xibaaru yoon
| Turu yoon | Dendreon Corporation |
|---|---|
| LEI | 549300C0XK81HDI8KK82Xool ci GLEIF ↗ |
| Adresu bindu | Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US |
| Nekkin | Dox |
Cosaan: GLEIF · yeesal Oct. 16, 2026
Jokkoo & lëkkalekaay
Barab
Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Ndax sa sosiete la?
Jël xët bii bu amul fay ngir yokk sa logo, yëf, nataal ak liggéey, te tontu xool.
Jël xët biiBokku ci Heelky ngir jokkoo, jëfandikoo ak yokkte
Sos kont bu amul fay ngir yónnee nit, jot liggéey te yónnee misiyooŋ.
Bokku léegi — amul fay